1. Home
  2. ATRO vs AVDL Comparison

ATRO vs AVDL Comparison

Compare ATRO & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astronics Corporation

ATRO

Astronics Corporation

HOLD

Current Price

$51.13

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.34

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATRO
AVDL
Founded
1968
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
ATRO
AVDL
Price
$51.13
$21.34
Analyst Decision
Strong Buy
Buy
Analyst Count
2
9
Target Price
$61.50
$18.38
AVG Volume (30 Days)
585.1K
2.8M
Earning Date
11-04-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$830,601,000.00
$248,517,000.00
Revenue This Year
$9.26
$65.47
Revenue Next Year
$11.51
$30.88
P/E Ratio
N/A
N/A
Revenue Growth
6.19
79.88
52 Week Low
$15.41
$6.38
52 Week High
$55.29
$23.57

Technical Indicators

Market Signals
Indicator
ATRO
AVDL
Relative Strength Index (RSI) 53.05 59.01
Support Level $49.51 $21.32
Resistance Level $55.02 $21.62
Average True Range (ATR) 2.49 0.34
MACD -0.06 -0.31
Stochastic Oscillator 54.29 6.90

Price Performance

Historical Comparison
ATRO
AVDL

About ATRO Astronics Corporation

Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: